{"id":"W3121448666","doi":"10.1200/jco.2021.39.3_suppl.tps152","title":"Platform trial of BI 754091, an anti-PD-1 antibody, in patients with previously treated advanced solid tumors: Combination with BI 836880, a VEGF/Ang2-blocking nanobody.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta","funders":"","keywords":"Medicine; Antibody; Chemotherapy; Bevacizumab; Internal medicine; Oncology; Progressive disease; Cancer; Cancer research; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007921187,0.0001776045,0.0009958441,0.0001263576,0.00004040849,0.00001593654,0.0001933614,0.0002539053,0.00001333497],"category_scores_gemma":[0.0006194587,0.0001222455,0.0001849838,0.0002548187,0.0001702015,0.00003850702,0.00006817858,0.0003521414,9.110519e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008721901,"about_ca_system_score_gemma":0.001645378,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006020688,"about_ca_topic_score_gemma":0.0006697247,"domain_scores_codex":[0.9973402,0.0003187551,0.00130834,0.0003099742,0.0004032539,0.0003195016],"domain_scores_gemma":[0.9973574,0.0001398665,0.001266461,0.0002496085,0.0007573829,0.0002293182],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2492027,0.01580705,0.6617286,0.00006478759,0.0009861414,0.0008099366,0.00009715929,0.000192437,0.01483957,0.00001992638,0.00009207588,0.05615966],"study_design_scores_gemma":[0.3187742,0.2046079,0.4337606,0.0005054126,0.0002402651,0.0001184069,0.0001604415,0.0000600033,0.03921963,0.0000922471,0.002104681,0.0003561147],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988233,0.0002016163,0.00004348905,0.0001417358,0.0001681919,0.0004121067,0.00001184211,0.000003441929,0.000194307],"genre_scores_gemma":[0.9983659,0.0004677822,0.0006773612,0.00009232233,0.0001789376,0.000009665026,0.0001467295,0.00002321218,0.00003802873],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2279679,"threshold_uncertainty_score":0.4985025,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04148958753402491,"score_gpt":0.4308969426276206,"score_spread":0.3894073550935957,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}